Journal
/
/
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
DOI:

07:24 min

May 25, 2022

, , , , , ,

Chapters

  • 00:04Introduction
  • 00:55Purification of NDV from Allantoic Fluid
  • 05:08Quality Control Assays
  • 05:55Results: Production of High-Titer Recombinant NDV
  • 06:53Conclusion

Summary

Automatic Translation

Here we provide a detailed procedure for production, purification, and quantification of high-titer recombinant Newcastle disease virus. This protocol consistently yields > 6 × 109 plaque-forming units/mL, providing virus quantities appropriate for in vivo animal studies. Additional quality control assays to ensure safety in vivo are described.

Related Videos

Read Article